Kinnate Biopharma Inc. to Participate in Upcoming Investor Conferences

Sangri Today

Jun 2, 2022 - 09:48

0

Kinnate Biopharma Inc. to Participate in Upcoming Investor Conferences

SAN FRANCISCO and SAN DIEGO, June 01, 2022 (GLOBE NEWSWIRE) -- Kinnate Biopharma Inc. (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology company, today announced that the company will participate in two upcoming in-person investor conferences:

Sangri Today Sangri Today is a Weekly Bilingual Newspaper and website of news and current affairs that publishes news reports from various places, from general reports.

Advertisement

Want to get your story featured as above? click here!

Advertisement

Want to get your story featured as above? click here!

Related Posts

Health Insurance Market Share [2022-2028] to reach USD 3.0386 Trillion [CAGR 5.5%] | Industry Size, Growth by Fortune Business Insights

Health Insurance Market Share [2022-2028] to reach USD ...

Sangri Today May 23, 2022 0

Ayurvedic Products Market to Reach USD 28,830 Million Revenue by 2030 at 12.3% CAGR – Report by Market Research Future (MRFR)

Ayurvedic Products Market to Reach USD 28,830 Million R...

Sangri Today May 23, 2022 0

Vaccitech to Present at the H.C. Wainwright Global Investment Conference

Vaccitech to Present at the H.C. Wainwright Global Inve...

Sangri Today May 23, 2022 0

Softgel Capsule Market Size Worth USD 11,050 Million by 2030 at 5.3% CAGR - Report by Market Research Future (MRFR)

Softgel Capsule Market Size Worth USD 11,050 Million by...

Sangri Today May 23, 2022 0

Home Infusion Therapy Market Size [2022 - 2028] to reach USD 54.82 Billion [CAGR 6.8%] | Industry Share, Segments , Trends, Growth by Fortune Business Insights

Home Infusion Therapy Market Size [2022 - 2028] to reac...

Sangri Today May 23, 2022 0

Exavir Therapeutics Completes $4M Seed Financing from Key Investors

Exavir Therapeutics Completes $4M Seed Financing from K...

Sangri Today May 23, 2022 0